高风险,高剂量吗? 用类固醇治疗的状脑膜炎的回顾性治疗结果
Harneet Dhillon1, Hannah Theodora Pescaru2, Shefali Dujari1
1Department of Neurology, Stanford University, Stanford, CA, USA.
The Neurohospitalist
|February 9, 2026
概括
高剂量的类固醇可以改善菌性脑膜炎 (CM) 患者与血管炎的结果. 虽然没有统计学意义,但高剂量的类固醇使用与低/中剂量相比,与死亡或血管炎的风险降低有关.
科学领域:
- 传染性疾病 传染性疾病
- 神经学 神经学
- 类风湿病学 类风湿病学
背景情况:
- 型血管炎是型脑膜炎 (CM) 的严重并发症.
- 类固醇被假设可以降低CM中的二次血管炎风险,但最佳剂量仍然不清楚.
- 这项研究调查了类固醇剂量对CM血管炎结果的影响.
研究的目的:
- 基于类固醇剂量,比较CM患者患有血管炎的特征和结果.
- 评估不同类固醇治疗方案与CM患者临床结果之间的关联.
主要方法:
- 使用斯坦福研究数据库 (1992-2024) 的回顾性队列研究.
- 已确定的成年患者患有状脑膜炎.
- 将患者分为没有类固醇,低/中剂量类固醇和高剂量类固醇组.
主要成果:
- 确定了65名CM患者;平均年龄45岁 (17),女性35%.
- 不服用类固醇的患者比服用类固醇的患者有更好的入院修改的兰金分数 (mRS ≤2).
- 高剂量类固醇接受者与低/中剂量接受者相比,显示死亡或血管炎风险降低的趋势 (32%的降低).
结论:
- 在患有血管炎的CM患者中使用类固醇与结果存在复杂的关系.
- 高剂量类固醇治疗可能与这种人群的改善长期结果有关.
- 需要对更大的队列进行进一步的研究来证实这些发现.
相关概念视频
Cranial and Spinal Meninges
4.1K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.1K
Field Procedure for Staking Out Curves
473
Staking out curves is an essential process in construction to ensure the accurate alignment of structures along a curved path. This task involves positioning stakes at calculated locations corresponding to the curve's design, effectively translating plans into physical markers in the field. The process begins by determining the geometric parameters of the curve, including the radius, central angle, and tangent distances. These parameters are critical for identifying key points such as the...
473
Predicting Reaction Outcomes
11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis
107.6K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.6K
Dose Size and Dosing Frequency: Determination Methods
318
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
318
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
248
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
248


